Study of Intralesional Cemiplimab in Adult Patients With Early Stage Cutaneous Squamous Cell Carcinoma

NCT06585410 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

369

Enrollment

INDUSTRY

Sponsor class

Conditions

Cutaneous Squamous Cell Carcinoma (CSCC)

Interventions

DRUG: Cemiplimab
PROCEDURE: Standard of care

Sponsor

Regeneron Pharmaceuticals